Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Andras Heczey, Xin Xu, Amy N. Courtney, Gengwen Tian, Gabriel A. Barragán, Linjie Guo, Claudia Martínez-Amador, Nisha Ghatwai, Purva Rathi, Michael S. Wood, Yanchuan Li, Chunchao Zhang, Thorsten Demberg, Erica J. Di Pierro, Andrew C. Sher, Huimin Zhang, Birju Mehta, Sachin G. Thakkar, Bambi Grilley, Tao Wang, Brian Weiss, Antonino Montalbano, Meena Subramaniam, Chenling Xu, Chirag Sachar, Daniel K. Wells, Gianpietro Dotti, Leonid S. Metelitsa
Topics & Concepts
MedicineChimeric antigen receptorNatural killer T cellImmunologyImmune systemRefractory (planetary science)CytokineNeuroblastomaImmunotherapyOncologyInternal medicineT cellBiologyCell cultureGeneticsAstrobiologyCAR-T cell therapy researchNeuroblastoma Research and TreatmentsImmune Cell Function and Interaction